baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Daiichi Sankyo Co., Ltd./ US23381D1028 /

2024-05-03 9:59:42 PM	Chg. +0.3800	Volume	Bid-	Ask-	High	Low
35.8600USD	+1.07%	63,825 Turnover: 2.01 mill.	-Bid Size: -	-Ask Size: -	36.8400	35.4900

GlobeNewswire 05-02 Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update

GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...

GlobeNewswire 04-29 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...

GlobeNewswire 03-29 Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

GlobeNewswire 03-22 CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose ...

GlobeNewswire 02-27 Esperion Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 02-15 Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

GlobeNewswire 01-03 Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including...

GlobeNewswire 2023-11-29 INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breas...

GlobeNewswire 2023-11-28 Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer

GlobeNewswire 2023-11-07 Esperion Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-11-02 Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update

GlobeNewswire 2023-11-02 vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer

TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 2023-10-02 Prevent Cancer Foundation raises more than $2 million for cancer prevention and early detection at a...

GlobeNewswire 2023-09-27 CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal includ...

GlobeNewswire 2023-09-13 Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Developm...

GlobeNewswire 2023-09-06 Jordanian royalty to grace Prevent Cancer Foundation 29th Annual Gala

GlobeNewswire 2023-08-31 RAIN Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in...

GlobeNewswire 2022-03-24 Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform

GlobeNewswire 2022-03-07 Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise

GlobeNewswire 2022-03-03 AIM ImmunoTech Appoints Robert Dickey, IV as Chief Financial Officer

GlobeNewswire 2022-03-01 Fight Colorectal Cancer is demanding MORE from Congress this March

GlobeNewswire 2022-02-22 Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver...

GlobeNewswire 2022-02-22 Esperion Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update

Daiichi Sankyo Co., Ltd./ US23381D1028 /

If you wish to receive reply to your feedback, please provide your email address.